EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Microfluidics-enabled polydopamine-coated selenium nanoparticles in hyaluronic hydrogel microspheres for targeted antioxidant and immunomodulatory therapy of ulcerative colitis

Ying Fang, Hongwei Yu, Xiaochen Feng, Haike Xia, Yunze Xu, Ranjith Kumar Kankala, Aizheng Chen, Chaoping Fu

Materials Today Bio · 2025-10 · 34 · 102182

DOI: 10.1016/j.mtbio.2025.102182 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Materials Today Bio, 2025-10. Verfasst von Ying Fang und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Materials Science and Engineering, Huaqiao University, Xiamen, Fujian, 361021, China. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Project of Nantong City, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ulcerative colitis (UC) is manifested by excessive oxidative stress and immune dysregulation in the colonic microenvironment. To address these pathological features, we developed a microfluidics-engineered oral delivery system comprising methacrylated hyaluronic acid (HAMA) hydrogel microspheres encapsulating polydopamine-coated selenium nanoparticles (CS-Se@PDA). The uniform microspheres featured a microfluidics-enabled structure that enabled stable CS-Se@PDA nanoparticles anchoring via electrostatic and covalent interactions. The PDA coating enhanced the stability, mucosal adhesion, and scavenging of reactive oxygen species (ROS) of the nanoparticles. At the same time, the HAMA shell provided pH-responsive protection and CD44-mediated targeting to inflamed colonic tissues. In vitro studies demonstrated excellent biocompatibility, effective ROS neutralization, and macrophage polarization toward the anti-inflammatory M2 phenotype. In a dextran sulfate sodium-induced colitis mouse model, oral administration of these microspheres significantly alleviated clinical symptoms, including ∼25 % mitigation of weight loss, increased colon length from 4.78 ± 0.3 cm to 6.83 ± 0.25 cm, and reduced histological damage. Furthermore, the treatment restored tight junction protein expression to approximately 60 % of normal levels for ZO-1 and about 55 % for Occludin, indicating substantial epithelial barrier repair, and effectively suppressed pro-inflammatory cytokines such as TNF-α and IL-6. Overall, this microfluidics-enabled, colon-targeted delivery system with integrated antioxidative and immunomodulatory functions offers a promising strategy for the non-invasive treatment of UC and other inflammation-associated gastrointestinal disorders.

Schlagwörter

Stichwörter der Autor:innen

Microfluidics-enabled hydrogel microspheresOral drug deliveryPolydopamineSelenium nanoparticlesUlcerative colitis

Autor:innen und Institutionen

  • College of Materials Science and Engineering, Huaqiao University, Xiamen, Fujian, 361021, China.
  • Fujian Provincial Key Laboratory of Biochemical Technology, Huaqiao University, Xiamen, Fujian, 361021, China.

Förderung

  • National Natural Science Foundation of China
  • Science and Technology Project of Nantong City
  • Fundamental Research Funds for the Central Universities
  • Science and Technology Projects of Fujian Province
  • Science and Technology Innovation Talents in Universities of Henan Province
  • Natural Science Foundation of Fujian Province

Zitieren

APA

Fang, Y., Yu, H., Feng, X., Xia, H., Xu, Y., Kankala, R. K., Chen, A., & Fu, C. (2025). Microfluidics-enabled polydopamine-coated selenium nanoparticles in hyaluronic hydrogel microspheres for targeted antioxidant and immunomodulatory therapy of ulcerative colitis. Materials Today Bio, 34, 102182. https://doi.org/10.1016/j.mtbio.2025.102182

Vancouver

Fang Y, Yu H, Feng X, Xia H, Xu Y, Kankala RK, et al. Microfluidics-enabled polydopamine-coated selenium nanoparticles in hyaluronic hydrogel microspheres for targeted antioxidant and immunomodulatory therapy of ulcerative colitis. Materials Today Bio. 2025;34:102182. doi:10.1016/j.mtbio.2025.102182

BibTeX
@article{Fang2025,
  author = {Fang, Ying and Yu, Hongwei and Feng, Xiaochen and Xia, Haike and Xu, Yunze and Kankala, Ranjith Kumar and Chen, Aizheng and Fu, Chaoping},
  title = {Microfluidics-enabled polydopamine-coated selenium nanoparticles in hyaluronic hydrogel microspheres for targeted antioxidant and immunomodulatory therapy of ulcerative colitis},
  journal = {Materials Today Bio},
  year = {2025},
  volume = {34},
  pages = {102182},
  doi = {10.1016/j.mtbio.2025.102182}
}
Kostenlos starten →